Annual Current Liabilities
$39.38 M
+$1.05 M+2.73%
31 December 2023
Summary:
Centessa Pharmaceuticals annual total current liabilities is currently $39.38 million, with the most recent change of +$1.05 million (+2.73%) on 31 December 2023. During the last 3 years, it has risen by +$30.77 million (+356.96%). CNTA annual current liabilities is now -65.72% below its all-time high of $114.90 million, reached on 01 June 2018.CNTA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$26.41 M
-$349.00 K-1.30%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly total current liabilities is currently $26.41 million, with the most recent change of -$349.00 thousand (-1.30%) on 30 September 2024. Over the past year, it has dropped by -$8.55 million (-24.45%). CNTA quarterly current liabilities is now -32.95% below its all-time high of $39.38 million, reached on 31 December 2023.CNTA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.7% | -24.4% |
| 3 y3 years | +357.0% | -9.4% |
| 5 y5 years | +95.8% | - |
CNTA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +357.0% | -33.0% | +7.2% |
| 5 y | 5 years | at high | +357.0% | -33.0% | +39.1% |
| alltime | all time | -65.7% | >+9999.0% | -33.0% | +39.1% |
Centessa Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $26.41 M(-1.3%) |
| June 2024 | - | $26.75 M(-2.5%) |
| Mar 2024 | - | $27.43 M(-30.3%) |
| Dec 2023 | $39.38 M(+2.7%) | $39.38 M(+12.7%) |
| Sept 2023 | - | $34.95 M(+3.2%) |
| June 2023 | - | $33.87 M(+14.1%) |
| Mar 2023 | - | $29.69 M(-22.6%) |
| Dec 2022 | $38.34 M(+55.6%) | $38.34 M(+0.4%) |
| Sept 2022 | - | $38.19 M(+13.8%) |
| June 2022 | - | $33.57 M(+23.4%) |
| Mar 2022 | - | $27.19 M(+10.4%) |
| Dec 2021 | $24.64 M | $24.64 M(-15.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $29.14 M(+20.5%) |
| June 2021 | - | $24.18 M(+27.4%) |
| Mar 2021 | - | $18.98 M |
| Dec 2020 | $8.62 M(-67.3%) | - |
| June 2020 | $26.33 M(+30.9%) | - |
| June 2019 | $20.12 M(-82.5%) | - |
| June 2018 | $114.90 M(+106.6%) | - |
| June 2017 | $55.61 M(+257.9%) | - |
| June 2016 | $15.54 M(+51.4%) | - |
| June 2015 | $10.26 M(>+9900.0%) | - |
| May 2015 | $51.70 K(-12.2%) | - |
| May 2014 | $58.90 K | - |
FAQ
- What is Centessa Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual current liabilities year-on-year change?
- What is Centessa Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly current liabilities year-on-year change?
What is Centessa Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CNTA is $39.38 M
What is the all time high annual current liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual total current liabilities is $114.90 M
What is Centessa Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CNTA annual total current liabilities has changed by +$1.05 M (+2.73%)
What is Centessa Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CNTA is $26.41 M
What is the all time high quarterly current liabilities for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly total current liabilities is $39.38 M
What is Centessa Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CNTA quarterly total current liabilities has changed by -$8.55 M (-24.45%)